280 related articles for article (PubMed ID: 10022832)
1. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.
Hoffmann R; Baillie GS; MacKenzie SJ; Yarwood SJ; Houslay MD
EMBO J; 1999 Feb; 18(4):893-903. PubMed ID: 10022832
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579.
Hill EV; Sheppard CL; Cheung YF; Gall I; Krause E; Houslay MD
Cell Signal; 2006 Nov; 18(11):2056-69. PubMed ID: 16973330
[TBL] [Abstract][Full Text] [Related]
3. In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.
McCahill A; McSorley T; Huston E; Hill EV; Lynch MJ; Gall I; Keryer G; Lygren B; Tasken K; van Heeke G; Houslay MD
Cell Signal; 2005 Sep; 17(9):1158-73. PubMed ID: 15905070
[TBL] [Abstract][Full Text] [Related]
4. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
[TBL] [Abstract][Full Text] [Related]
5. ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions.
MacKenzie SJ; Baillie GS; McPhee I; Bolger GB; Houslay MD
J Biol Chem; 2000 Jun; 275(22):16609-17. PubMed ID: 10828059
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting.
Liu H; Maurice DH
J Biol Chem; 1999 Apr; 274(15):10557-65. PubMed ID: 10187850
[TBL] [Abstract][Full Text] [Related]
7. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases.
Baillie GS; MacKenzie SJ; McPhee I; Houslay MD
Br J Pharmacol; 2000 Oct; 131(4):811-9. PubMed ID: 11030732
[TBL] [Abstract][Full Text] [Related]
8. Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK).
Baillie G; MacKenzie SJ; Houslay MD
Mol Pharmacol; 2001 Nov; 60(5):1100-11. PubMed ID: 11641439
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation.
Ang KL; Antoni FA
J Neurochem; 2002 May; 81(3):422-33. PubMed ID: 12065651
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
Sette C; Conti M
J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
[TBL] [Abstract][Full Text] [Related]
11. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model.
Hoffmann R; Wilkinson IR; McCallum JF; Engels P; Houslay MD
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):139-49. PubMed ID: 9639573
[TBL] [Abstract][Full Text] [Related]
12. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.
Baillie GS; Sood A; McPhee I; Gall I; Perry SJ; Lefkowitz RJ; Houslay MD
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):940-5. PubMed ID: 12552097
[TBL] [Abstract][Full Text] [Related]
13. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation.
Oki N; Takahashi SI; Hidaka H; Conti M
J Biol Chem; 2000 Apr; 275(15):10831-7. PubMed ID: 10753877
[TBL] [Abstract][Full Text] [Related]
14. PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.
Carlisle Michel JJ; Dodge KL; Wong W; Mayer NC; Langeberg LK; Scott JD
Biochem J; 2004 Aug; 381(Pt 3):587-92. PubMed ID: 15182229
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
16. The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site.
Grange M; Sette C; Cuomo M; Conti M; Lagarde M; Prigent AF; Némoz G
J Biol Chem; 2000 Oct; 275(43):33379-87. PubMed ID: 10938092
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
Herman SB; Juilfs DM; Fauman EB; Juneau P; Menetski JP
Mol Pharmacol; 2000 May; 57(5):991-9. PubMed ID: 10779384
[TBL] [Abstract][Full Text] [Related]
18. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
[TBL] [Abstract][Full Text] [Related]
19. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways.
Dodge-Kafka KL; Soughayer J; Pare GC; Carlisle Michel JJ; Langeberg LK; Kapiloff MS; Scott JD
Nature; 2005 Sep; 437(7058):574-8. PubMed ID: 16177794
[TBL] [Abstract][Full Text] [Related]
20. The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways.
Houslay MD; Baillie GS
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1186-90. PubMed ID: 14641023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
